{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T07:01:41Z","timestamp":1792047701372,"version":"4.4.0"},"reference-count":53,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2024,11,1]]},"abstract":"<jats:sec id=\"ab-yoi240044-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Antidepressant discontinuation substantially increases the risk of a depression relapse, but the neurobiological mechanisms through which this happens are not known. Amygdala reactivity to negative information is a marker of negative affective processes in depression that is reduced by antidepressant medication, but it is unknown whether amygdala reactivity is sensitive to antidepressant discontinuation or whether any change is related to the risk of relapse after antidepressant discontinuation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-yoi240044-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate whether amygdala reactivity to negative facial emotions changes with antidepressant discontinuation and is associated with subsequent relapse.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-yoi240044-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>The Antidepressiva Absetzstudie (AIDA) study was a longitudinal, observational study in which adult patients with remitted major depressive disorder (MDD) and currently taking antidepressants underwent 2 task-based functional magnetic resonance imaging (fMRI) measurements of amygdala reactivity. Patients were randomized to discontinuing antidepressants either before or after the second fMRI measurement. Relapse was monitored over a 6-month follow-up period. Study recruitment took place from June 2015 to January 2018. Data were collected between July 1, 2015, and January 31, 2019, and statistical analyses were conducted between June 2021 and December 2023. The study took place in a university setting in Zurich, Switzerland, and Berlin, Germany. Of 123 recruited patients, 83 were included in analyses. Of 66 recruited healthy control individuals matched for age, sex, and education, 53 were included in analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-yoi240044-7\">\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>Discontinuation of antidepressant medication.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-yoi240044-8\">\n                    <jats:title>Outcomes<\/jats:title>\n                    <jats:p>Task-based fMRI measurement of amygdala reactivity and MDD relapse within 6 months after discontinuation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-yoi240044-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among patients with MDD, the mean (SD) age was 35.42 (11.41) years, and 62 (75%) were women. Among control individuals, the mean (SD) age was 33.57 (10.70) years, and 37 (70%) were women. Amygdala reactivity of patients with remitted MDD and taking medication did not initially differ from that of control individuals (\n                      <jats:italic>t<\/jats:italic>\n                      <jats:sub>125.136<\/jats:sub>\n                      \u2009=\u20090.33;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009\n                      <jats:italic>=<\/jats:italic>\n                      \u2009.74). An increase in amygdala reactivity after antidepressant discontinuation was associated with depression relapse (3-way interaction between group [12W (waited) vs 1W2 (discontinued)], time point [MA1 (first scan) vs MA2 (second scan)], and relapse: \u03b2, 18.9; 95% CI, 0.8-37.1;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009\n                      <jats:italic>=<\/jats:italic>\n                      \u2009.04). Amygdala reactivity change was associated with shorter times to relapse (hazard ratio, 1.05; 95% CI, 1.01-1.09;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009\n                      <jats:italic>=<\/jats:italic>\n                      \u2009.01) and predictive of relapse (leave-one-out cross-validation balanced accuracy, 67%; 95% posterior predictive interval, 53-80;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.02).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-yoi240044-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>An increase in amygdala reactivity was associated with risk of relapse after antidepressant discontinuation and may represent a functional neuroimaging marker that could inform clinical decisions around antidepressant discontinuation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamapsychiatry.2024.2136","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T11:07:14Z","timestamp":1726052834000},"page":"1081","source":"Crossref","is-referenced-by-count":18,"title":["Amygdala Reactivity, Antidepressant Discontinuation, and Relapse"],"prefix":"10.1001","volume":"81","author":[{"given":"Tore","family":"Erdmann","sequence":"first","affiliation":[{"name":"Applied Computational Psychiatry Lab, Mental Health Neuroscience Department, Division of Psychiatry and Max Planck Centre for Computational Psychiatry and Ageing Research, Queen Square Institute of Neurology, University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel M.","family":"Berwian","sequence":"additional","affiliation":[{"name":"Princeton Neuroscience Institute & Psychology Department, Princeton University, Princeton, New Jersey"},{"name":"Translational Neuromodeling Unit, University of Zurich and Swiss Federal Institute of Technology in Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaas Enno","family":"Stephan","sequence":"additional","affiliation":[{"name":"Translational Neuromodeling Unit, University of Zurich and Swiss Federal Institute of Technology in Zurich, Zurich, Switzerland"},{"name":"Max Planck Institute for Metabolism Research, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich","family":"Seifritz","sequence":"additional","affiliation":[{"name":"Department of Adult Psychiatry and Psychotherapy, Hospital of Psychiatry, University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Walter","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Charit\u00e9-Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin J. M.","family":"Huys","sequence":"additional","affiliation":[{"name":"Applied Computational Psychiatry Lab, Mental Health Neuroscience Department, Division of Psychiatry and Max Planck Centre for Computational Psychiatry and Ageing Research, Queen Square Institute of Neurology, University College London, London, United Kingdom"},{"name":"Translational Neuromodeling Unit, University of Zurich and Swiss Federal Institute of Technology in Zurich, Zurich, Switzerland"},{"name":"Department of Adult Psychiatry and Psychotherapy, Hospital of Psychiatry, University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"yoi240044r1","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey replication.","volume":"62","author":"Ronald","year":"2005","journal-title":"Arch Gen Psychiatry"},{"issue":"11","key":"yoi240044r3","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1001\/jamapsychiatry.2015.1813","article-title":"Self-blame-selective hyperconnectivity between anterior temporal and subgenual cortices and prediction of recurrent depressive episodes.","volume":"72","author":"Lythe","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"yoi240044r4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1037\/abn0000031","article-title":"A two-factor model of relapse\/recurrence vulnerability in unipolar depression.","volume":"124","author":"Farb","year":"2015","journal-title":"J Abnorm Psychol"},{"key":"yoi240044r5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cpr.2018.07.005","article-title":"Risk factors for relapse and recurrence of depression in adults and how they operate: a four-phase systematic review and meta-synthesis.","volume":"64","author":"Buckman","year":"2018","journal-title":"Clin Psychol Rev"},{"issue":"9358","key":"yoi240044r6","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S0140-6736(03)12599-8","article-title":"Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review.","volume":"361","author":"Geddes","year":"2003","journal-title":"Lancet"},{"issue":"14","key":"yoi240044r7","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1056\/NEJMoa2106356","article-title":"Maintenance or discontinuation of antidepressants in primary care.","volume":"385","author":"Lewis","year":"2021","journal-title":"N Engl J Med"},{"issue":"8","key":"yoi240044r8","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3109\/00048671003705441","article-title":"Meta-analysis of relapse prevention antidepressant trials in depressive disorders.","volume":"44","author":"Glue","year":"2010","journal-title":"Aust N Z J Psychiatry"},{"issue":"6","key":"yoi240044r9","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3109\/10673229809003578","article-title":"Discontinuing antidepressant treatment in major depression.","volume":"5","author":"Viguera","year":"1998","journal-title":"Harv Rev Psychiatry"},{"issue":"9","key":"yoi240044r10","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.4088\/JCP.v69n0910","article-title":"Evidence that patients with single versus recurrent depressive episodes are differentially sensitive to treatment discontinuation: a meta-analysis of placebo-controlled randomized trials.","volume":"69","author":"Kaymaz","year":"2008","journal-title":"J Clin Psychiatry"},{"issue":"9","key":"yoi240044r11","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/archpsyc.1991.01810330075011","article-title":"Conceptualization and rationale for consensus definitions of terms in major depressive disorder. remission, recovery, relapse, and recurrence.","volume":"48","author":"Frank","year":"1991","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"yoi240044r12","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1017\/S0033291716002580","article-title":"Predicting relapse after antidepressant withdrawal - a systematic review.","volume":"47","author":"Berwian","year":"2017","journal-title":"Psychol Med"},{"issue":"1","key":"yoi240044r13","doi-asserted-by":"publisher","first-page":"11171","DOI":"10.1038\/s41598-022-13893-9","article-title":"Low predictive power of clinical features for relapse prediction after antidepressant discontinuation in a naturalistic setting.","volume":"12","author":"Berwian","year":"2023","journal-title":"Sci Rep"},{"issue":"5","key":"yoi240044r14","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1001\/jamapsychiatry.2019.4971","article-title":"Computational mechanisms of effort and reward decisions in patients with depression and their association with relapse after antidepressant discontinuation.","volume":"77","author":"Berwian","year":"2023","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"yoi240044r15","doi-asserted-by":"publisher","first-page":"22346","DOI":"10.1038\/s41598-020-79170-9","article-title":"The relationship between resting-state functional connectivity, antidepressant discontinuation and depression relapse.","volume":"10","author":"Berwian","year":"2020","journal-title":"Sci Rep"},{"issue":"2","key":"yoi240044r16","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1192\/bjp.bp.108.051193","article-title":"Why do antidepressants take so long to work? a cognitive neuropsychological model of antidepressant drug action.","volume":"195","author":"Harmer","year":"2009","journal-title":"Br J Psychiatry"},{"issue":"8","key":"yoi240044r17","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nrn3027","article-title":"Neural mechanisms of the cognitive model of depression.","volume":"12","author":"Disner","year":"2011","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"yoi240044r18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/npp.2011.183","article-title":"Cognitive mechanisms of treatment in depression.","volume":"37","author":"Roiser","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"yoi240044r19","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s00213-019-05448-0","article-title":"Cognitive neuropsychological theory of antidepressant action: a modern-day approach to depression and its treatment.","volume":"238","author":"Godlewska","year":"2021","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"yoi240044r20","doi-asserted-by":"publisher","first-page":"451","DOI":"10.4088\/JCP.10m06584","article-title":"Successful pharmacologic treatment of major depressive disorder attenuates amygdala activation to negative facial expressions: a functional magnetic resonance imaging study.","volume":"73","author":"Ruh\u00e9","year":"2012","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"yoi240044r21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/2045-5380-1-10","article-title":"Facial emotion processing in major depression: a systematic review of neuroimaging findings.","volume":"1","author":"Stuhrmann","year":"2011","journal-title":"Biol Mood Anxiety Disord"},{"issue":"3","key":"yoi240044r22","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/mp.2014.24","article-title":"Neuropsychological mechanism underlying antidepressant effect: a systematic meta-analysis.","volume":"20","author":"Ma","year":"2015","journal-title":"Mol Psychiatry"},{"issue":"4","key":"yoi240044r23","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1172\/JCI38454","article-title":"Targeted electrode-based modulation of neural circuits for depression.","volume":"119","author":"Mayberg","year":"2009","journal-title":"J Clin Invest"},{"issue":"7","key":"yoi240044r24","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1176\/appi.ajp.21050466","article-title":"No association between amygdala responses to negative faces and depressive symptoms: cross-sectional data from 28,638 individuals in the UK Biobank cohort.","volume":"179","author":"Tamm","year":"2022","journal-title":"Am J Psychiatry"},{"issue":"12","key":"yoi240044r25","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1017\/S0033291712000591","article-title":"Short-term SSRI treatment normalises amygdala hyperactivity in depressed patients.","volume":"42","author":"Godlewska","year":"2012","journal-title":"Psychol Med"},{"issue":"9","key":"yoi240044r26","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.biopsych.2005.10.015","article-title":"Antidepressant drug treatment modifies the neural processing of nonconscious threat cues.","volume":"59","author":"Harmer","year":"2006","journal-title":"Biol Psychiatry"},{"issue":"6","key":"yoi240044r27","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.neuropharm.2008.06.036","article-title":"Serotonin and emotional processing: does it help explain antidepressant drug action?","volume":"55","author":"Harmer","year":"2008","journal-title":"Neuropharmacology"},{"issue":"2","key":"yoi240044r28","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.cpr.2009.11.004","article-title":"Emotion-regulation strategies across psychopathology: a meta-analytic review.","volume":"30","author":"Aldao","year":"2010","journal-title":"Clin Psychol Rev"},{"issue":"11","key":"yoi240044r29","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1093\/cercor\/bht154","article-title":"Cognitive reappraisal of emotion: a meta-analysis of human neuroimaging studies.","volume":"24","author":"Buhle","year":"2014","journal-title":"Cereb Cortex"},{"issue":"9","key":"yoi240044r30","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S0006-3223(01)01263-X","article-title":"Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study.","volume":"50","author":"Sheline","year":"2001","journal-title":"Biol Psychiatry"},{"key":"yoi240044r31","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2022.103157","article-title":"MRI predictors of pharmacotherapy response in major depressive disorder.","volume":"36","author":"Gerlach","year":"2022","journal-title":"Neuroimage Clin"},{"issue":"1-2","key":"yoi240044r32","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jad.2010.09.032","article-title":"Brain effects of antidepressants in major depression: a meta-analysis of emotional processing studies.","volume":"130","author":"Delaveau","year":"2011","journal-title":"J Affect Disord"},{"issue":"2","key":"yoi240044r33","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1007\/s11682-020-00299-2","article-title":"Abnormal neural activities in adults and youths with major depressive disorder during emotional processing: a meta-analysis.","volume":"15","author":"Li","year":"2021","journal-title":"Brain Imaging Behav"},{"issue":"4","key":"yoi240044r34","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1192\/bjp.2021.16","article-title":"Neural effects of antidepressant medication and psychological treatments: a quantitative synthesis across three meta-analyses.","volume":"219","author":"Nord","year":"2021","journal-title":"Br J Psychiatry"},{"issue":"3","key":"yoi240044r35","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1016\/j.neuroimage.2012.01.129","article-title":"Test-retest reliability of evoked BOLD signals from a cognitive-emotive fMRI test battery.","volume":"60","author":"Plichta","year":"2012","journal-title":"Neuroimage"},{"issue":"5580","key":"yoi240044r36","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1126\/science.1071829","article-title":"Serotonin transporter genetic variation and the response of the human amygdala.","volume":"297","author":"Hariri","year":"2002","journal-title":"Science"},{"issue":"1","key":"yoi240044r37","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/wps.20015","article-title":"When does depression become a disorder? using recurrence rates to evaluate the validity of proposed changes in major depression diagnostic thresholds.","volume":"12","author":"Wakefield","year":"2013","journal-title":"World Psychiatry"},{"issue":"3","key":"yoi240044r40","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1017\/S0033291700035558","article-title":"The Inventory of Depressive Symptomatology (IDS): psychometric properties.","volume":"26","author":"Rush","year":"1996","journal-title":"Psychol Med"},{"key":"yoi240044r43","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2466\/pms.1958.8.3.271","article-title":"Validity of the trail making test as an indicator of organic brain damage.","volume":"8","author":"Reitan","year":"1958","journal-title":"Percept Mot Skills"},{"issue":"10","key":"yoi240044r46","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1038\/npp.2015.89","article-title":"Amygdala reactivity to emotional faces in the prediction of general and medication-specific responses to antidepressant treatment in the Randomized iSPOT-D Trial.","volume":"40","author":"Williams","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"yoi240044r48","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.biopsych.2012.04.031","article-title":"Reversed frontotemporal connectivity during emotional face processing in remitted depression.","volume":"72","author":"Goulden","year":"2012","journal-title":"Biol Psychiatry"},{"issue":"7","key":"yoi240044r49","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1001\/archpsyc.63.7.749","article-title":"Cognitive reactivity to sad mood provocation and the prediction of depressive relapse.","volume":"63","author":"Segal","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"yoi240044r50","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.biopsych.2011.03.009","article-title":"Mood-linked responses in medial prefrontal cortex predict relapse in patients with recurrent unipolar depression.","volume":"70","author":"Farb","year":"2011","journal-title":"Biol Psychiatry"},{"key":"yoi240044r51","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2022.102969","article-title":"Static and treatment-responsive brain biomarkers of depression relapse vulnerability following prophylactic psychotherapy: Evidence from a randomized control trial.","volume":"34","author":"Farb","year":"2022","journal-title":"Neuroimage Clin"},{"issue":"1","key":"yoi240044r52","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1006\/nimg.2002.1179","article-title":"The amygdala response to emotional stimuli: a comparison of faces and scenes.","volume":"17","author":"Hariri","year":"2002","journal-title":"Neuroimage"},{"key":"yoi240044r53","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1146\/annurev.neuro.051508.135335","article-title":"The neurobiology of individual differences in complex behavioral traits.","volume":"32","author":"Hariri","year":"2009","journal-title":"Annu Rev Neurosci"},{"key":"yoi240044r2","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013","edition":"5th Ed"},{"key":"yoi240044r38","volume-title":"Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I\/P)","author":"First","year":"2002"},{"key":"yoi240044r39","author":"Brodersen","year":"2010"},{"key":"yoi240044r41","volume-title":"Mehrfachwahl-Wortschatz-Intelligenztest MWT-B","author":"Lehrl","year":"2005"},{"key":"yoi240044r42","volume-title":"Wechsler Adult Intelligence Scale Revised","author":"Wechsler","year":"1981"},{"key":"yoi240044r45","volume-title":"Cognitive Therapy of Depression","author":"Beck","year":"1979"},{"key":"yoi240044r44","doi-asserted-by":"crossref","unstructured":"Volkmann? C, Abulikemu? S, Berwian? IM, Huys? Q, Walter? H. Do discontinuation symptoms predict depression relapse after antidepressant cessation?? PsyArXiv. Preprint posted online February 22, 2023. doi:10.31234\/osf.io\/fxye5","DOI":"10.31234\/osf.io\/fxye5"},{"key":"yoi240044r47","doi-asserted-by":"crossref","unstructured":"Berwian? IM, Tr\u00f6ndle? M, de Miquel? C, . Emotion-induced frontal asymmetry predicts relapse after discontinuation of antidepressant medication.? bioRxiv. Preprint posted online July 7, 2023. doi:10.1101\/2023.07.05.547831","DOI":"10.1101\/2023.07.05.547831"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2823590\/jamapsychiatry_erdmann_2024_oi_240044_1730747560.21707.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T11:01:19Z","timestamp":1730890879000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2823590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":53,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2024.2136","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,1]]}}}